1ST Biotherapeutics, Inc.

With the state-run Korea Drug Development Fund (KDDF), which plays a key role in providing R&D support to the country’s biopharma industry, already midway through its current 10-year term, the fun

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Deal Brings AstraZeneca Greater C

At the grand ballroom of the Conrad Hotel in Seoul, hundreds of people were eagerly waiting for the conference to begin, while many others who couldn’t find seats were instructed to move to a second b

Three biopharma firms were scheduled to launch initial public offerings during the week of 9-13 November but all three postponed or delayed their offerings, raising the question of whether the booming